Selank + Semax

This product is currently out of stock and unavailable.

100% delivery

  • Done Satisfaction Guaranteed
  • Done No Hassle Refunds
  • Done Secure Payments
GUARANTEED SAFE CHECKOUT
  • Visa Card
  • MasterCard
SKU: selank-semax Category:

Description

For Research Use Only. Not for Human or Veterinary Use.
Neurological10mg*10vialsHPLC ≥ 99%COA per batch

Selank+Semax

SK+XA,ChemSpider 9940290 · CAS 129954-34-3,Wikipedia · CAS 80714-61-0

Specifications:
Click to preview COA & reports online View all COA
Selank+Semax
TL;DR

Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) is a synthetic heptapeptide analogue of tuftsin; Semax (Met-Glu-His-Phe-Pro-Gly-Pro) is a synthetic heptapeptide analogue of an ACTH fragment. Both contain a C-terminal Pro-Gly-Pro extension and are supplied for laboratory research.

Overview

Selank is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro, derived from the endogenous tetrapeptide tuftsin by addition of a C-terminal Pro-Gly-Pro motif.

Semax is a synthetic heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro, corresponding to a modified ACTH fragment with the same C-terminal Pro-Gly-Pro extension.

Both peptides are provided as lyophilized research materials with full analytical documentation.

What are Selank and Semax?

Selank (CAS 129954-34-3) is a seven-residue peptide (H-Thr-Lys-Pro-Arg-Pro-Gly-Pro-OH) with molecular formula C33H57N11O9 and average molecular weight approximately 751.9 g/mol. It is a structural analogue of the endogenous tetrapeptide tuftsin (Thr-Lys-Pro-Arg) extended by Pro-Gly-Pro. Semax (CAS 80714-61-0) is a seven-residue peptide (H-Met-Glu-His-Phe-Pro-Gly-Pro-OH) with molecular formula C37H51N9O10S and average molecular weight approximately 813.9 g/mol. It is a synthetic analogue of an ACTH fragment incorporating the same C-terminal Pro-Gly-Pro sequence.

Structural features

Both peptides are linear heptapeptides containing three proline residues and the shared C-terminal Pro-Gly-Pro motif. Selank contains basic residues (Lys, Arg); Semax contains a methionine residue and an acidic residue (Glu). Neither contains cysteine or disulfide bonds.

Characterization

Each batch is HPLC-purified and mass-confirmed, with identity, purity and net peptide content documented on the Certificate of Analysis.

Key Highlights

  • Synthetic heptapeptides for laboratory research
  • Selank: tuftsin analogue, sequence TKPRPGP (CAS 129954-34-3)
  • Semax: ACTH-fragment analogue, sequence MEHFPGP (CAS 80714-61-0)
  • Shared C-terminal Pro-Gly-Pro structural motif
  • ≥99% purity verified by HPLC & Mass Spectrometry
  • Lyophilized solid peptides
  • Research-grade material

Safety & Side Effects

Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) is a synthetic heptapeptide analogue of tuftsin; Semax (Met-Glu-His-Phe-Pro-Gly-Pro) is a synthetic heptapeptide analogue of an ACTH fragment. Both contain a C-terminal Pro-Gly-Pro extension and are supplied for laboratory research. When used in research, Selank + Semax should be handled in a qualified laboratory setting, and its safety profile should be interpreted strictly within the experimental context in which it was studied.

Published selank + semax side effects data are limited to experimental models and are specific to the dose, route, and study design employed. Investigators should account for neurological and neuroprotective pathways readouts and any off-target effects relevant to the compound’s mechanism when designing a study.

For authoritative safety and toxicology references, consult peer-reviewed databases (PubMed, PubChem) and review the batch Certificate of Analysis before designing your protocol.

Dosage & Protocol

There is no standardized human dosage for Selank + Semax; it is supplied strictly for laboratory research. Reported selank + semax dosage values in the literature are derived from preclinical studies and are specific to the study model, route, and experimental design.

Research protocols typically document selank + semax dosage together with reconstitution method, storage conditions, and analytical confirmation of identity (CAS Selank: 129954-34-3 Semax: 80714-61-0 分子式, molecular formula Selank: C33H57N11O9 Semax: C37H51N9O10S, molecular weight Selank: 751.9 g/mol Semax: 813.9 g/mol). Because dose-response relationships may not scale across models, investigators should base their design on peer-reviewed methods rather than informal community reports.

Always confirm the exact strength, purity, and lot-specific data from the batch COA before weighing or reconstituting your sample.

Comparison

PeptideSequenceMolecular weight
SelankThr-Lys-Pro-Arg-Pro-Gly-Pro751.9 g/mol
SemaxMet-Glu-His-Phe-Pro-Gly-Pro813.9 g/mol

How to Order

1

Enquiry

Send strength and quantity for a quote.

2

Quotation

Price, lead time and specification confirmed.

3

QC & COA

HPLC/LC‑MS tested; COA issued.

4

Delivery

Tracked worldwide shipping.

Specifications

Product nameSelank+Semax
Product codeXK10
Specification10mg*10vials
CAS numberSelank: 129954-34-3 Semax: 80714-61-0 分子式
Molecular formulaSelank: C33H57N11O9 Semax: C37H51N9O10S
Molecular weightSelank: 751.9 g/mol Semax: 813.9 g/mol
Purity≥99% (subject to batch COA)
Physical FormLyophilized white to off-white solid powder
SolubilitySoluble in bacteriostatic water
Amino Acid Count7 residues each

Applications

ResearchLaboratoryAcademicDrug Discovery

Packaging & Shipping

Available pack sizes

10mg*10vials20mg*10vials

Shipping

WorldwideCold ChainExpress

Storage & Handling

Store lyophilized at −20 °C, protected from light and moisture. Bring to room temperature before opening. After reconstitution, refrigerate and avoid repeated freeze-thaw cycles.

Additional information

Specification

10mg*10vials, 20mg*10vials